Who
Jennifer Sy
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, AEON Biopharma.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Aug 2024
- Last trade
- 4 Mar 2026
- Last filed
- 5 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 5 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —925,925 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —925,925 at $0.00 | filing |
| 17 Feb 2026filed 5 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —575,000 at $0.00 | filing |
| 17 Feb 2026filed 5 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —575,000 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —925,925 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,063 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —18,010 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.